Quarles & Brady has significant experience assisting health care clients in navigating the complex world of the 340B Drug Pricing Program. Our team includes two partner who started their professional careers as pharmacists, one of whom was the owner of an independent pharmacy. The entire team has considerable 340B drafting, negotiating, and advisement experience. This combination of real-life, relevant experience from pharmacist and pharmacy owner perspectives, coupled with our legal experience, enables us to provide unparalleled advice to clients.
Brenda Maloney Shafer is a member of Quarles & Brady’s Health Law Practice Group. Her practice focuses primarily in health law and, in particular, health care regulatory and transactional work. Along with her law degree, she holds a Master’s of Law in Health Law. A particular area of focus is counseling clients regarding compliance with the 340B Drug Pricing Program.
Richard Davis has extensive experience with the 340B Program and has worked with both contract pharmacies and covered entities to develop and optimize their program participation. His practice also focuses on a wide variety of pharmacy regulatory issues, including controlled substances and state licensure compliance.
Jaya White is a partner in the firm’s Health Law Practice Group. She represents a wide range of health care clients in regulatory and transactional matters, primarily in the pharmacy and long-term care industries. A portion of her practice includes assisting pharmacy and hospital clients with issues involving the 340B Discount Drug Program and contract pharmacy issues.
Elizabeth Gebarski focuses her practice in the areas of hospital and health law. Her practice includes advising clients on regulatory and compliance issues, business development, and licensing issues. She is well-versed in providing 340B Drug Pricing Program regulatory, compliance, audit, and contract support to covered entities, contract pharmacies, and other key stakeholders.